2022年《ASMBS/IFSO减重与代谢手术适应证指南》解读  

Interpretation of the 2022 ASMBS/IFSO Guidelines for Bariatric and Metabolic Surgery Indications

作　　者：董志勇[1] 王存川[1] Dong Zhiyong;Wang Cunchuan(Department of Metabolic and Bariatric Surgery/Bariatric Center,The First Affiliated Hospital of Jinan University,Guangzhou 510630,China)

机构地区：[1]暨南大学附属第一医院肥胖代谢外科/减重中心,广州510630

出　　处：《中华肥胖与代谢病电子杂志》2023年第4期225-230,共6页Chinese Journal Of Obesity and Metabolic Diseases：Electronic Edition

摘　　要：随着时间的推移和大量临床研究证据的出现,2022年美国代谢减重外科学会(ASMBS)和国际肥胖和代谢疾病外科联合会(IFSO)联合发布的新指南在多个方面对1991年美国国立卫生研究院(NIH)发表的共识进行了更新。新版指南降低了减重手术的BMI门槛,鼓励更多符合手术指征的患者接受手术。手术类型以腹腔镜微创入路为主,以袖状胃切除术(SG)和Roux-en-Y胃旁路术(RYGB)为主流手术方式。新版指南还强调了手术的安全性和有效性,证实手术可降低总体死亡率,改善心血管风险和癌症风险;年龄上不再限制,老年和儿童/青少年群体均可考虑减重手术;修正手术以及减重手术在其他手术治疗前的应用。本文旨在对最新指南进行全面的解读。With the passage of time and the emergence of a wealth of clinical research evidence,the new guidelines jointly released by ASMBS and IFSO in 2022 have made substantial updates to the 1991 NIH consensus across multiple aspects.The revised guidelines have lowered the BMI threshold for bariatric surgery,aiming to encourage a greater number of patients to consider undergoing the procedure.The predominant surgical approaches include laparoscopic minimally invasive procedures,sleeve gastrectomy and Roux-en-Y gastric bypass(RYGB).Furthermore,the updated guidelines underscore the safety and effectiveness of these surgeries,confirming their ability to reduce overall mortality rates and mitigate cardiovascular and cancer risks.Age is no longer a limiting factor,as both elderly individuals and the pediatric/adolescent populations are now eligible candidates for weight loss surgery.Revisional procedures are also mentioned in the article,along with the application of weight loss surgery as a preparatory measure prior to other surgical treatments.This paper summarizes the key updates of the latest guidelines.

关 键 词：ASMBS IFSO 减重代谢手术 袖状胃切除术 ROUX-EN-Y胃旁路术 适应证 指南 

分 类 号：R656[医药卫生—外科学]